8-K current report · filed Oct 19, 2026

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) 8-K Current Report: October 19, 2026

Item 1.01Item 1.02Item 2.03Item 7.01Item EX-99.1IART overview

Short answer

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) filed an 8-K current report with the SEC on October 19, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). $1.65B secured credit package: $600M revolver, $600M Term Loan A, $450M Term Loan B.

INTEGRA LIFESCIENCES HOLDINGS CORP 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • $1.65B secured credit package: $600M revolver, $600M Term Loan A, $450M Term Loan B
  • $450M senior secured notes at 9.500%, maturing November 1, 2033
  • Term Loan B spread 4.25%; revolver and Term Loan A initially priced at 3.00% over Term SOFR
  • Heavy financing cost and leverage sensitivity, with collateral pledged and debt guaranteed by domestic subsidiaries
  • Restrictive covenants limit additional debt, liens, dividends, investments, asset sales and affiliate transactions

Item 1.02 · Termination of a Material Definitive Agreement

  • Existing Credit Agreement fully repaid and terminated on October 19, 2026
  • Refinancing funded with Credit Agreement borrowings and Notes offering proceeds
  • Replaced $1.3B revolving facility and $775M term loan facility
  • No early termination penalties incurred
  • Outstanding letters of credit transferred under the new Credit Agreement

Item 2.03 · Creation of a Direct Financial Obligation

  • Item 2.03 links to Item 1.01 for details on a newly created direct financial obligation
  • Investors must review Item 1.01 to assess obligation size, terms, maturity and potential balance-sheet impact

Item 7.01 · Regulation FD Disclosure

  • Closing of credit agreement and notes offering announced on October 19, 2026
  • New financing provides capital but increases debt obligations and future interest requirements
  • Exhibit 99.1 contains the transaction terms and financing details

Item EX-99.1 · Exhibit EX-99.1

  • $450.0M senior secured notes issued at 9.500%, maturing 2033, increasing fixed-cost debt burden
  • Refinanced approximately $1.65B credit facility, including $600M revolver, $600M term loan A and $450M term loan B
  • Proceeds and new borrowings used to refinance existing debt and pay transaction expenses
  • Notes and guarantees unregistered, limiting liquidity and resale primarily to qualified institutional buyers and certain non-U.S. investors

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other INTEGRA LIFESCIENCES HOLDINGS CORP 8-K filings

Get the next IART 8-K as it lands

Follow IART for push alerts, or ask the research agent what this filing means.